Latest News and Press Releases
Want to stay updated on the latest news?
-
Alexandria, VA, May 01, 2026 (GLOBE NEWSWIRE) -- In 2025, 97,000 people under the age of 18 in the United States took a depression screening on Mental Health America’s website, and 51% reported...
-
The latest GeneSight® Mental Health Monitor from Myriad Genetics reveals that Americans feel mental health treatment isn’t designed with them in mind.
-
DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...
-
Glendale, April 27, 2026 (GLOBE NEWSWIRE) -- Glendale, Calif. – The Chicago School today announced that its Southern California Campus will host its 2026 commencement ceremonies on May 1, 2026, at...
-
York, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- WellSpan Health and community partners gathered today to mark the opening of the WellSpan Behavioral Health Walk-In Crisis Center in York, expanding...
-
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by...
-
EMP-01 demonstrated a large, clinically meaningful reduction in patient-reported SAD symptoms at Day 43: placebo-adjusted LSMD -11.5 points (p=0.002) on SPIN; placebo-adjusted LSMD -15.6 points...
-
Cette nomination renforce la gouvernance d'Elkedonia alors que la société poursuit son développement et prépare ses prochaines étapes de croissancePierre d'Epenoux est l'ancien Président Directeur...
-
Appointment strengthens Elkedonia's governance as the company continues its development and prepares for its next phases of growthPierre d’Epenoux is former CEO of ImCheck Therapeutics, a...
-
DUBLIN, April 20, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...